New Tech “Add-On” Payments Sought By Hospital On Behalf Of Firms
This article was originally published in The Gray Sheet
Executive Summary
CardiacAssist hopes to obtain new technology "add-on" inpatient reimbursement for its TandemHeart percutaneous vascular assist device (PVAD), which will be used in an estimated 200 cardiogenic shock cases in 2005
You may also be interested in...
AdvaMed, MDMA Take Issue With CMS’ New Tech Add-On Payment Policy
CMS' proposed redefinition of "new" technologies contradicts Medicare statute, according to AdvaMed
AdvaMed, MDMA Take Issue With CMS’ New Tech Add-On Payment Policy
CMS' proposed redefinition of "new" technologies contradicts Medicare statute, according to AdvaMed
CMS New Tech Add-On Interpretation Contested By Industry Reps
Medtronic will attempt to persuade CMS that the firm's Kinetra deep-brain stimulation device marks a substantial clinical improvement over its predecessor - the dual-implant Soletra - and therefore qualifies for a new technology "add-on" payment